Gugnani H C
Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, India.
Eur J Epidemiol. 1999 Nov;15(10):923-9. doi: 10.1023/a:1007656818038.
Zygomycosis due to Basidiobolus ranarum (entomophthoromycosis basidiobolae, subcutaneous zygomycosis, subcutaneous phycomycosis, basidiobolomycosis) is a granulomatous infection of the skin and subcutaneous tissues characterized by the formation of fluctuant firm and non-tender swellings, generally on the extremities, trunk and rarely other parts of the body. The causative agent is common in soil, decaying vegetable matter, and the gastrointestinal tracts of amphibians, reptiles, fish and bats. It is presumed that infection is acquired through exposure to B. ranarum following minor trauma to skin or insect bites. The disease usually occurs in children, less often in adolescents and rarely in adults. Males are much more frequently affected than females. Laboratory diagnosis is based on histopathology and culture. The typical histopathological feature is the presence of thin-walled, broad often aseptate hyphae or hyphal fragments with an eosinophilic sheath, frequently phagocytized within giant cells. Basidiobolus ranarum is known to produce several enzymes, e.g. lipase and protease that probably play roles in the pathogenesis of infections caused by this mould. An immunological test has been developed for specific diagnosis of the disease. Though potassium iodide (KI) has been the traditional drug employed in the treatment of infections by B. ranarum, several other drugs, viz amphotericin B, cotrimoxazole, ketoconazole, itraconazole and fluconazole have been successfully tried.
由蛙粪霉引起的接合菌病(蛙粪霉虫霉病、皮下接合菌病、皮下藻菌病、蛙粪霉病)是一种皮肤和皮下组织的肉芽肿性感染,其特征为形成波动感的坚实且无压痛的肿胀,通常出现在四肢、躯干,很少见于身体其他部位。病原体在土壤、腐烂的植物物质以及两栖动物、爬行动物、鱼类和蝙蝠的胃肠道中常见。据推测,感染是在皮肤受到轻微创伤或被昆虫叮咬后接触蛙粪霉而获得的。该病通常发生于儿童,青少年较少见,成人罕见。男性受累远比女性频繁。实验室诊断基于组织病理学和培养。典型的组织病理学特征是存在薄壁、宽大且常无隔膜的菌丝或菌丝片段,带有嗜酸性鞘,常被巨细胞吞噬。已知蛙粪霉能产生多种酶,如脂肪酶和蛋白酶,它们可能在这种霉菌引起的感染发病机制中起作用。已开发出一种用于该病特异性诊断的免疫学检测方法。尽管碘化钾(KI)一直是治疗蛙粪霉感染的传统药物,但其他几种药物,即两性霉素B、复方新诺明、酮康唑、伊曲康唑和氟康唑也已成功试用。